SEC Comment Letter 0000000000-24-007148 to Organon & Co. (OGN) (CIK 0001821825) (OGN)
Organon & Co. (OGN) (CIK 0001821825)
Date: June 25, 2024 · CIK: 0001821825 · Accession: 0000000000-24-007148
AI Filing Summary & Sentiment
File numbers found in text: 001-40235
Letter
United States securities and exchange commission logo June 25, 2024 Matthew Walsh Chief Financial Officer Organon & Co. 30 Hudson Street, Floor 33 Jersey City, New Jersey 07302 Re:Organon & Co. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-40235 Dear Matthew Walsh: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 25, 2024
Matthew Walsh
Chief Financial Officer
Organon & Co.
30 Hudson Street, Floor 33
Jersey City, New Jersey 07302
Re:Organon & Co.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-40235
Dear Matthew Walsh:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences